다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.29 no.3, 1998년, pp.430 - 436
Grangie, J.-D. (Services d'Hepatologie, Hopital tenon, ,, Paris, France) , Roulot, D. , Pelletier, G. , Pariente, E.-A. , Denis, J. , Ink, O. , Blanc, P. , Richardet, J.P. , Vinel, J.P. , Delisle, F. , Fischer, D. , Flahault, A. , Amiot, X.
AI-Helper
Background/Aims: Norfloxacin is useful to prevent infections in hospitalized cirrhotic patients with low ascitic fluid protein concentrations. It is also effective in preventing the recurrence of spontaneous bacterial peritonitis. The aim of our study was to determine the efficacy of norfloxacin in ...
Hepatology Hoefs 2 399 1982 10.1002/hep.1840020402 Spontaneous bacerial peritonitis
Gastroenterol Clin North Am Garcia-Tsao 21 257 1992 10.1016/S0889-8553(21)00617-8 Spontaneous bacterial peritonitis
Hepatology Grangé 11 360 1990 10.1002/hep.1840110305 Amoxicilin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients
J Gastroenterol Hepatol Altman 10 47 1995 10.1111/j.1440-1746.1995.tb01046.x Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation
J Hepatol Runyon 21 792 1994 10.1016/S0168-8278(94)80241-6 Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis
Gastroenterology Garcia-Tsao 108 1835 1995 10.1016/0016-5085(95)90147-7 Bacterial translocation to mesenteric lymph nodes is increased in cirrhosis rats with ascites
Ann Intern Med Karp 106 1 1987 10.7326/0003-4819-106-1-1 Oral norfloxacin for prevention of Gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial
Am J Med Winston 88 36 1990 10.1016/0002-9343(90)90125-W Ofloxacin versus Vancomycin/polymyxin for prevention of infections in granulocytopenic patients
Hepatology Ginès 12 716 1990 10.1002/hep.1840120416 Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial
Hepatology Llach 16 724 1992 10.1002/hep.1840160318 Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhotic ascites: relevance of ascitic fluid protein concentration
Gastroenterology Runyon 91 1343 1986 10.1016/0016-5085(86)90185-X Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis
Gastroenterology Soriano 100 477 1991 10.1016/0016-5085(91)90219-B Selective intestinal decontamination prevents spontaneous bacterial peritonitis
Hepatology Rolachon 22 1171 1995 Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial
Ann Intern Med Singh 122 595 1995 10.7326/0003-4819-122-8-199504150-00007 Trimethoprimsulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial
Hepatology Runyon 12 710 1990 10.1002/hep.1840120415 Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis
J Hepatol Pelletier 10 327 1990 10.1016/0168-8278(90)90140-M Culture-negative neutrocytic ascites: a less severe variant of spontaneous bacterial peritonitis
Gastroenterol Clin Biol Denis 5 951 1981 Infections spontanées du liquide de'ascite chez le cirrhotique: supériorité bactériologique de l'ensemencement direct en milieu liquide
Gastroenterology Runyon 95 1351 1988 10.1016/0016-5085(88)90372-1 Optimization of ascitic fluid culture technique
Hepatology Sainz 9 662 1989 10.1002/hep.1840090430 More on ascitic fluid culture technique [letter]
Hepatology Rimola 5 463 1985 10.1002/hep.1840050320 Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
Gastroenterol Hepatol Ginès 13 325 1990 Efecto de la administracion de norfloxacino sobre la flora fecal en pacientes cirroticos
Gastroenterol Clin Biol Grangé 16 692 1992 La prophylaxie des complications infectieuses par décontamination bactérienne digestive sélective chez les malades atteints de cirrhose
Br Med J 307 525 1993 10.1136/bmj.307.6903.525 Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomised controlled trials of selective decontamination ofthe digestive tract
Antimicrob Agents Chemother King 21 604 1982 10.1128/AAC.21.4.604 In vivo antibacterial activity of norfloxacin (MK-0366)
Gut Wyke 28 623 1987 10.1136/gut.28.5.623 Problems of bacterial infection in patients with liver disease
Antimicrob Agents Chemother Raz 35 1241 1991 10.1128/AAC.35.6.1241 Long-term prophylaxis with norfloxacin versus nitrofurantoinin women with recurrent urinary tract infection
Hepatology Tito 8 27 1988 10.1002/hep.1840080107 Recurrence of spontaneous bacerial peritonitis in cirrhosis: frequency and predictive factors
Gastroenterology Navasa 108 1132 1995 10.1016/0016-5085(95)28829-5 High prevalence and prognostic significance of hepatocellular carcinoma (HCC) in cirrhotic patients with spontaneous bacterial peritonitis (SBP)
Hepatology Novella 25 532 1997 10.1002/hep.510250306 Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin
Antimicrob Agents Chemother Dupeyron 38 340 1994 10.1128/AAC.38.2.340 Rapid emergency of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis
J Hepatol Younossi 27 295 1997 10.1016/S0168-8278(97)80174-2 An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis
Gastroenterology Inadomi 113 1289 1997 10.1053/gast.1997.v113.pm9322524 Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis
Am J Med Moore 101 34 1996 10.1016/S0002-9343(96)00077-0 Adverse events from drug therapy for human immunodeficiency virus disease
Med Mal Inf Philippon 26 539 1996 10.1016/S0399-077X(96)80239-3 Escherichia coli: fréquence de résistance et évolution à divers antibiotiques urinaires dont la fosfomycine en milieu hospitalier (11 816 souches, 1991-1995)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.